HIF-α Promotes Chronic Myelogenous Leukemia Cell Proliferation by Upregulating p21 Expression

UCN-01 induces S and G2/M cell cycle arrest through the p53/p21waf1or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines

(2013) Guoyi Wu et al.   BMC CANCER

The Critical Impact of HIF-1a on Gastric Cancer Biology

(2013) Yoshihiko Kitajima et al.   Cancers

BCR-ABL expression in leukemic progenitors and primitive stem cells of patients with chronic myeloid leukemia

(2012) J.-C. Chomel et al.   BLOOD

JKA97, a Novel Benzylidene Analog of Harmine, Exerts Anti-Cancer Effects by Inducing G1 Arrest, Apoptosis, and p53-Independent Up-Regulation of p21

(2012) Xinyi Yang et al.   PLoS One

Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence

(2011) S. S. Oladipupo et al.   BLOOD

RXR antagonism induces G0/G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21$^{\rm{Cip1}}$ pathway in adipocytes

(2011) Atsuko Nakatsuka et al.   JOURNAL OF PATHOLOGY

Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications

(2010) Jui-Han Huang et al.   CANCER BIOLOGY & THERAPY

Rare variant of hypoxia-inducible factor-1α (HIF-1A) and breast cancer risk in Korean women

(2008) Ji-Young Lee et al.   CLINICA CHIMICA ACTA